{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:29:53Z","timestamp":1792466993026,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100005258","name":"National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention","doi-asserted-by":"publisher","award":["NU38PS004644"],"award-info":[{"award-number":["NU38PS004644"]}],"id":[{"id":"10.13039\/100005258","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K23 DA044085"],"award-info":[{"award-number":["K23 DA044085"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA046527"],"award-info":[{"award-number":["R01 DA046527"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P30 DA040500"],"award-info":[{"award-number":["P30 DA040500"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P30AI042853"],"award-info":[{"award-number":["P30AI042853"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s11606-020-05701-9","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T18:02:47Z","timestamp":1583344967000},"page":"1477-1483","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid Epidemic"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5169-620X","authenticated-orcid":false,"given":"Sabrina A.","family":"Assoumou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayla","family":"Nolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golnaz","family":"Eftekhari Yazdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth H.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Puro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin P.","family":"Linas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,4]]},"reference":[{"key":"5701_CR1","unstructured":"Centers for Disease Control and Prevention. Surveillance for Viral Hepatitis - United States, 2017. 2017. https:\/\/www.cdc.gov\/hepatitis\/statistics\/2016surveillance\/index.htm. Accessed September 18, 2019."},{"issue":"17","key":"5701_CR2","first-page":"453","volume":"64","author":"JE Zibbell","year":"2015","unstructured":"Zibbell JE, Iqbal K, Patel RC, Suryaprasad A, Sanders KJ, Moore-Moravian L et al. Increases in hepatitis C virus infection related to injection drug use among persons aged \u226430 years \u2013 Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012. MMWR Morb Mortal Wkly Rep. 2015;64(17):453\u2013458.","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"5701_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.2105\/AJPH.2017.304132","volume":"2017","author":"JE Zibbell","year":"2014","unstructured":"Zibbell JE, Asher AK, Patel RC, et al. Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014. Am J Public Health. 2017:e1-e7. doi:https:\/\/doi.org\/10.2105\/AJPH.2017.304132","journal-title":"Am J Public Health."},{"issue":"42","key":"5701_CR4","first-page":"1457","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","unstructured":"Centers for Disease Control and Prevention. Notes from the field: risk factors for hepatitis C virus infections among young adults \u2013 Massachusetts, 2010. MMWR Morb Mortal Wkly Rep. 2011;60(42):1457\u20131458.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR-4","key":"5701_CR5","first-page":"1","volume":"61","author":"BD Smith","year":"2012","unstructured":"Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Teo CG et al. Recommendations for the Identification of Chronic Hepatitis C Virus Infection Among Persons Born During 1945\u20131965. MMWR Recomm Rep. 2012;61(RR-4):1\u201332.","journal-title":"MMWR Recomm Rep"},{"key":"5701_CR6","unstructured":"U.S. Preventive Services Task Force (USPSTF). Draft Recommendation Statement: Hepatitis C Virus Infection in Adolescents and Adults: Screening - US Preventive Services Task Force. https:\/\/www.uspreventiveservicestaskforce.org\/Page\/Document\/draft-recommendation-statement\/hepatitis-c-screening1. Accessed September 23, 2019."},{"issue":"6","key":"5701_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1089\/apc.2015.0314","volume":"30","author":"KH Mayer","year":"2016","unstructured":"Mayer KH, Crawford P, Dant L, Gillespie S, Singal R, Vandermeer M et al. HIV and Hepatitis C Virus Screening Practices in a Geographically Diverse Sample of American Community Health Centers. AIDS Patient Care STDS. 2016;30(6):237\u2013246.","journal-title":"AIDS Patient Care STDS."},{"issue":"20","key":"5701_CR8","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1056\/NEJMoa1402355","volume":"370","author":"KV Kowdley","year":"2014","unstructured":"Kowdley KV, Gordon SC, Reddy KR, Rossaro L, Bernstein DE, Lawitz E et al. Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis. N Engl J Med. 2014;370(20):1879\u20131888.","journal-title":"N Engl J Med."},{"issue":"20","key":"5701_CR9","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","volume":"368","author":"E Lawitz","year":"2013","unstructured":"Lawitz E, Mangia A, Wyles D, Rodriguez-Torres M, Hassanein T, Gordon SC et al. Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl J Med. 2013;368(20):1878\u20131887.","journal-title":"N Engl J Med."},{"issue":"4","key":"5701_CR10","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s11606-017-4280-y","volume":"33","author":"D Guss","year":"2018","unstructured":"Guss D, Sherigar J, Rosen P MS. Diagnosis and Management of Hepatitis C Infection in Primary Care Settings. J Gen Intern Med. 2018;33(4):551\u2013557.","journal-title":"J Gen Intern Med."},{"issue":"1","key":"5701_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/jvh.12611","volume":"24","author":"EB Tapper","year":"2017","unstructured":"Tapper EB, Bacon BR, Curry MP, Dieterich DT, Flamm SL, Guest LE et al. Real-world effectiveness for 12 weeks of ledipasvir-sofosbuvir for genotype 1 hepatitis C: the Trio Health study. J Viral Hepat. 2017;24(1):22\u201327.","journal-title":"J Viral Hepat."},{"issue":"6","key":"5701_CR12","first-page":"SP205","volume":"22","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Park H, Gordon SC, Ferguson JR, Ahmed A, Dieterich D et al. Real-World Outcomes of Ledipasvir\/Sofosbuvir in Treatment-Na\u00efve Patients With Hepatitis C. Am J Manag Care. 2016;22(6):SP205\u201311.","journal-title":"Am J Manag Care"},{"issue":"4","key":"5701_CR13","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1353\/hpu.2017.0118","volume":"28","author":"SA Assoumou","year":"2017","unstructured":"Assoumou SA, Huang W, Young K, Horsburgh CR LB. Real-world Outcomes of Hepatitis C Treatment during the Interferon-free Era at an Urban Safety-net Hospital. J Heal Care Poor Underserved. 2017;28(4):1333\u20131344.","journal-title":"J Heal Care Poor Underserved."},{"issue":"6","key":"5701_CR14","first-page":"S1188\u2013S","volume":"154","author":"ZT Alam","year":"2018","unstructured":"Alam ZT, Malik H, Hinds CC, Niquette J AI. Hepatitis C Treatment with Ledipasvir and Sofosbuvir in a Low Socioeconomic Population at a Federally Qualified Health Center [Fqhc]. Gastroenterology. 2018;154(6):S1188\u2013S.","journal-title":"Gastroenterology"},{"issue":"3","key":"5701_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3122\/jabfm.2013.03.120234","volume":"26","author":"JESA Devoe","year":"2013","unstructured":"Devoe JE SA. The OCHIN community information network: bringing together community health centers, information technology, and data to support a patient-centered medical village. J Am Board Fam Med. 2013;26(3):271\u2013278.","journal-title":"J Am Board Fam Med."},{"key":"5701_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.drugpo.2018.02.001","volume":"55","author":"NZ Janjua","year":"2018","unstructured":"Janjua NZ, Islam N, Kuo M, et al. Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets. Int J Drug Policy. 2018;55:31\u201339. doi:https:\/\/doi.org\/10.1016\/j.drugpo.2018.02.001","journal-title":"Int J Drug Policy."},{"key":"5701_CR17","unstructured":"OCHIN. Who We Serve. Facts about Vulnerable Patients. https:\/\/ochin.org\/vulnerable-patients-the-facts. Accessed September 18, 2019."},{"issue":"3","key":"5701_CR18","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/hep.24105","volume":"53","author":"ZH Lin","year":"2011","unstructured":"Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011;53(3):726\u2013736.","journal-title":"Hepatology."},{"issue":"5","key":"5701_CR19","doi-asserted-by":"publisher","first-page":"372","DOI":"10.7326\/0003-4819-158-11-201306040-00005","volume":"159","author":"RWN Chou","year":"2013","unstructured":"Chou R WN. Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection. Ann Intern Med. 2013;159(5):372. doi:https:\/\/doi.org\/10.7326\/0003-4819-158-11-201306040-00005","journal-title":"Ann Intern Med."},{"issue":"1","key":"5701_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: An inexpensive and accurajte marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology. 2007;46(1):32\u201336. doi:https:\/\/doi.org\/10.1002\/hep.21669","journal-title":"Hepatology."},{"key":"5701_CR21","unstructured":"Centers for Disease Control and Prevention. Statistics & Surveillance | Division of Viral Hepatitis | CDC. Viral Hepatitis - Statistics & Surveillance. https:\/\/www.cdc.gov\/hepatitis\/statistics\/index.htm. Published 2016. Accessed September 18, 2019."},{"issue":"3","key":"5701_CR22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa1515195","volume":"375","author":"PJ Peters","year":"2016","unstructured":"Peters PJ, Pontones P, Hoover KW, Patel MR, Galang RR, Shields J et al. HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015. N Engl J Med. 2016;375(3):229\u2013239.","journal-title":"N Engl J Med."},{"key":"5701_CR23","unstructured":"Vo QT, Onofrey S, Church D, Cranston K, DeMaria A, Klevens R. The Massachusetts Hepatitis C Testing Cascade, 2014-2016. Microbiol Insights. 2019;12:1178636119857961."},{"key":"5701_CR24","unstructured":"Centers for Disease Control and Prevention. National Ambulatory Medical Care Survey: 2016 National Summary Tables. https:\/\/www.cdc.gov\/nchs\/data\/ahcd\/namcs_summary\/2016_namcs_web_tables.pdf. Accessed September 19, 2019."},{"key":"5701_CR25","doi-asserted-by":"publisher","unstructured":"Barua S, Greenwald R, Grebely J, Dore GJ, Swan TT LE. Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States. Ann Intern Med. 2015;163(3):215\u2013223. doi:https:\/\/doi.org\/10.7326\/M15-0406","DOI":"10.7326\/M15-0406"},{"issue":"10","key":"5701_CR26","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1093\/cid\/ciu643","volume":"59","author":"AG Suryaprasad","year":"2014","unstructured":"Suryaprasad AG, White JZ, Xu F, Eichler BA, Hamilton J, Patel A et al. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012. Clin Infect Dis. 2014;59(10):1411\u20131419.","journal-title":"Clin Infect Dis."},{"issue":"3","key":"5701_CR27","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1370\/afm.2069","volume":"15","author":"K Lasser","year":"2017","unstructured":"Lasser K, Heinz A, Battisti L, et al. A Hepatitis C Treatment Program Based in a Safety-Net Hospital Patient-Centered Medical Home. Ann Fam Med. 2017;15(3):258\u2013261. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5422088\/pdf\/0150258.pdf. Accessed September 18, 2019.","journal-title":"Ann Fam Med."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-05701-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11606-020-05701-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-05701-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T01:04:53Z","timestamp":1614819893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11606-020-05701-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,4]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["5701"],"URL":"https:\/\/doi.org\/10.1007\/s11606-020-05701-9","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,4]]},"assertion":[{"value":"19 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The Boston University Medical Center Institutional Review Board approved the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB Approval"}},{"value":"The authors declare that they do not have a conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The findings and conclusions of this study are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention or the National Institutes of Health.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}